Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
New medicines: human
Get the latest updates from New medicines: human directly as they happen.
Follow now 562 followers
Latest posts
Last updated 9 days ago
Human medicines European public assessment report (EPAR): Xervyteg, Allogeneic faecal microbiota, pooled, Status: Opinion
28 days ago
Human medicines European public assessment report (EPAR): Xervyteg, Allogeneic faecal microbiota, pooled...
Human medicines European public assessment report (EPAR): Tacquell, Autologous melanoma-derived tumor infiltrating lymphocytes, ex vivo-expanded, Status: Opinion
28 days ago
Human medicines European public assessment report (EPAR): Tacquell, Autologous melanoma-derived tumor infiltrating...
Human medicines European public assessment report (EPAR): Onswik, Insulin efsitora alfa, Status: Opinion
28 days ago
Human medicines European public assessment report (EPAR): Onswik, Insulin efsitora alfa, Status...
Human medicines European public assessment report (EPAR): Nylaspeg, pegfilgrastim, Status: Opinion
28 days ago
Human medicines European public assessment report (EPAR): Nylaspeg, pegfilgrastim, Status: Opinion
Human medicines European public assessment report (EPAR): Hopledo, levodopa,carbidopa, Status: Opinion
28 days ago
Human medicines European public assessment report (EPAR): Hopledo, levodopa,carbidopa, Status: Opinion
Human medicines European public assessment report (EPAR): Denosumab Ascend, denosumab, Status: Opinion
28 days ago
Human medicines European public assessment report (EPAR): Denosumab Ascend, denosumab, Status: Opinion
Human medicines European public assessment report (EPAR): Aujemflu, Influenza vaccine (surface antigen, inactivated, adjuvanted, prepared in cell culture), Status: Opinion
28 days ago
Human medicines European public assessment report (EPAR): Aujemflu, Influenza vaccine (surface antigen...
Human medicines European public assessment report (EPAR): Yartemlea, Narsoplimab, Status: Opinion under re-examination
9 days ago
Human medicines European public assessment report (EPAR): Yartemlea, Narsoplimab, Status: Opinion under...
Human medicines European public assessment report (EPAR): Xervyteg, Allogeneic faecal microbiota, pooled, Status: Opinion
28 days ago
Human medicines European public assessment report (EPAR): Xervyteg, Allogeneic faecal microbiota, pooled...
Human medicines European public assessment report (EPAR): Yartemlea, Narsoplimab, Status: Opinion
28 days ago
Human medicines European public assessment report (EPAR): Yartemlea, Narsoplimab, Status: Opinion
Human medicines European public assessment report (EPAR): Tacquell, Autologous melanoma-derived tumor infiltrating lymphocytes, ex vivo-expanded, Status: Opinion
28 days ago
Human medicines European public assessment report (EPAR): Tacquell, Autologous melanoma-derived tumor infiltrating...
Human medicines European public assessment report (EPAR): Onswik, Insulin efsitora alfa, Status: Opinion
28 days ago
Human medicines European public assessment report (EPAR): Onswik, Insulin efsitora alfa, Status...